

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 9.79926700 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 9.74983720 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.35287280 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.35287280 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.04442220 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.04442220 |
| 7 | drug metabolic process (GO:0017144) | 6.64046156 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.57763099 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.47725893 |
| 10 | oxidative demethylation (GO:0070989) | 6.03701444 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 5.90500405 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 5.90500405 |
| 13 | tryptophan catabolic process (GO:0006569) | 5.90500405 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.82470930 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.81763349 |
| 16 | negative regulation of fibrinolysis (GO:0051918) | 5.79438060 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 5.73771224 |
| 18 | glyoxylate metabolic process (GO:0046487) | 5.71593203 |
| 19 | alpha-linolenic acid metabolic process (GO:0036109) | 5.68813576 |
| 20 | tryptophan metabolic process (GO:0006568) | 5.59169733 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.53745715 |
| 22 | protein carboxylation (GO:0018214) | 5.53745715 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.53465323 |
| 24 | urea cycle (GO:0000050) | 5.50371345 |
| 25 | urea metabolic process (GO:0019627) | 5.50371345 |
| 26 | opsonization (GO:0008228) | 5.46590601 |
| 27 | ethanol metabolic process (GO:0006067) | 5.43645325 |
| 28 | regulation of protein activation cascade (GO:2000257) | 5.26867684 |
| 29 | complement activation, alternative pathway (GO:0006957) | 5.24010131 |
| 30 | sulfur amino acid catabolic process (GO:0000098) | 5.18666376 |
| 31 | cysteine metabolic process (GO:0006534) | 5.16680193 |
| 32 | reverse cholesterol transport (GO:0043691) | 5.06146680 |
| 33 | nitrogen cycle metabolic process (GO:0071941) | 5.04180739 |
| 34 | bile acid metabolic process (GO:0008206) | 4.99563763 |
| 35 | negative regulation of protein activation cascade (GO:2000258) | 4.99253743 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 4.93365608 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 4.93078338 |
| 38 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.92982477 |
| 39 | protein-lipid complex remodeling (GO:0034368) | 4.90455679 |
| 40 | macromolecular complex remodeling (GO:0034367) | 4.90455679 |
| 41 | plasma lipoprotein particle remodeling (GO:0034369) | 4.90455679 |
| 42 | regulation of complement activation (GO:0030449) | 4.90136374 |
| 43 | phenylpropanoid metabolic process (GO:0009698) | 4.82223901 |
| 44 | regulation of humoral immune response (GO:0002920) | 4.81814986 |
| 45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.81428025 |
| 46 | regulation of triglyceride catabolic process (GO:0010896) | 4.79035036 |
| 47 | aromatic amino acid family metabolic process (GO:0009072) | 4.77483437 |
| 48 | S-adenosylmethionine metabolic process (GO:0046500) | 4.75685017 |
| 49 | acute-phase response (GO:0006953) | 4.71862870 |
| 50 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.68282574 |
| 51 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.68282574 |
| 52 | tyrosine metabolic process (GO:0006570) | 4.67550720 |
| 53 | plasma lipoprotein particle clearance (GO:0034381) | 4.65920227 |
| 54 | phospholipid efflux (GO:0033700) | 4.64888128 |
| 55 | negative regulation of blood coagulation (GO:0030195) | 4.64432052 |
| 56 | negative regulation of hemostasis (GO:1900047) | 4.64432052 |
| 57 | regulation of plasminogen activation (GO:0010755) | 4.62013990 |
| 58 | triglyceride homeostasis (GO:0070328) | 4.60995708 |
| 59 | acylglycerol homeostasis (GO:0055090) | 4.60995708 |
| 60 | homocysteine metabolic process (GO:0050667) | 4.56133510 |
| 61 | negative regulation of cholesterol transport (GO:0032375) | 4.55469033 |
| 62 | negative regulation of sterol transport (GO:0032372) | 4.55469033 |
| 63 | alpha-amino acid catabolic process (GO:1901606) | 4.48429129 |
| 64 | amino-acid betaine metabolic process (GO:0006577) | 4.48287185 |
| 65 | lysine metabolic process (GO:0006553) | 4.42051897 |
| 66 | lysine catabolic process (GO:0006554) | 4.42051897 |
| 67 | cholesterol efflux (GO:0033344) | 4.36984944 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 4.35858829 |
| 69 | bile acid and bile salt transport (GO:0015721) | 4.29405841 |
| 70 | flavonoid metabolic process (GO:0009812) | 4.29398300 |
| 71 | glycine metabolic process (GO:0006544) | 4.27348655 |
| 72 | imidazole-containing compound metabolic process (GO:0052803) | 4.23401477 |
| 73 | negative regulation of coagulation (GO:0050819) | 4.23149869 |
| 74 | indolalkylamine metabolic process (GO:0006586) | 4.20882478 |
| 75 | negative regulation of wound healing (GO:0061045) | 4.18431030 |
| 76 | fibrinolysis (GO:0042730) | 4.16190788 |
| 77 | plasma lipoprotein particle assembly (GO:0034377) | 4.16088010 |
| 78 | coenzyme catabolic process (GO:0009109) | 4.15787657 |
| 79 | arginine metabolic process (GO:0006525) | 4.13614601 |
| 80 | cellular glucuronidation (GO:0052695) | 4.13423276 |
| 81 | glutamate metabolic process (GO:0006536) | 4.10472928 |
| 82 | cellular amino acid catabolic process (GO:0009063) | 4.10021422 |
| 83 | alkaloid metabolic process (GO:0009820) | 4.09514060 |
| 84 | amine catabolic process (GO:0009310) | 4.08003503 |
| 85 | cellular biogenic amine catabolic process (GO:0042402) | 4.08003503 |
| 86 | low-density lipoprotein particle remodeling (GO:0034374) | 4.05275592 |
| 87 | blood coagulation, intrinsic pathway (GO:0007597) | 4.04105281 |
| 88 | aldehyde catabolic process (GO:0046185) | 4.00528888 |
| 89 | hormone catabolic process (GO:0042447) | 3.99958009 |
| 90 | benzene-containing compound metabolic process (GO:0042537) | 3.99531423 |
| 91 | serine family amino acid metabolic process (GO:0009069) | 3.98315827 |
| 92 | negative regulation of complement activation (GO:0045916) | 3.91200193 |
| 93 | cellular modified amino acid catabolic process (GO:0042219) | 3.89967946 |
| 94 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.88723235 |
| 95 | ethanol oxidation (GO:0006069) | 3.88191037 |
| 96 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.86274531 |
| 97 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.86274531 |
| 98 | phospholipid homeostasis (GO:0055091) | 3.84765076 |
| 99 | intestinal cholesterol absorption (GO:0030299) | 3.84527241 |
| 100 | drug catabolic process (GO:0042737) | 3.81075586 |
| 101 | serine family amino acid biosynthetic process (GO:0009070) | 3.80461692 |
| 102 | cholesterol homeostasis (GO:0042632) | 3.80246715 |
| 103 | cofactor catabolic process (GO:0051187) | 3.79702817 |
| 104 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.78372539 |
| 105 | protein activation cascade (GO:0072376) | 3.77327477 |
| 106 | plasma lipoprotein particle organization (GO:0071827) | 3.77298906 |
| 107 | protein-lipid complex assembly (GO:0065005) | 3.76037639 |
| 108 | positive regulation of lipid catabolic process (GO:0050996) | 3.75986667 |
| 109 | ketone body metabolic process (GO:1902224) | 3.75588264 |
| 110 | sterol homeostasis (GO:0055092) | 3.73968823 |
| 111 | positive regulation of hemostasis (GO:1900048) | 3.72514629 |
| 112 | positive regulation of blood coagulation (GO:0030194) | 3.72514629 |
| 113 | negative regulation of lipase activity (GO:0060192) | 3.69602644 |
| 114 | glucuronate metabolic process (GO:0019585) | 3.68896716 |
| 115 | uronic acid metabolic process (GO:0006063) | 3.68896716 |
| 116 | complement activation (GO:0006956) | 3.64599823 |
| 117 | complement activation, classical pathway (GO:0006958) | 3.63222127 |
| 118 | regulation of cholesterol homeostasis (GO:2000188) | 3.60478453 |
| 119 | organic acid catabolic process (GO:0016054) | 3.60418464 |
| 120 | carboxylic acid catabolic process (GO:0046395) | 3.60418464 |
| 121 | protein-lipid complex subunit organization (GO:0071825) | 3.56546374 |
| 122 | lipoprotein metabolic process (GO:0042157) | 3.55961458 |
| 123 | xenobiotic metabolic process (GO:0006805) | 3.51764781 |
| 124 | regulation of bile acid biosynthetic process (GO:0070857) | 3.48638459 |
| 125 | heme transport (GO:0015886) | 3.46220063 |
| 126 | short-chain fatty acid metabolic process (GO:0046459) | 3.46161046 |
| 127 | acetyl-CoA metabolic process (GO:0006084) | 3.45585703 |
| 128 | acute inflammatory response (GO:0002526) | 3.45564021 |
| 129 | cytolysis (GO:0019835) | 3.43957407 |
| 130 | positive regulation of coagulation (GO:0050820) | 3.42525262 |
| 131 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.37643639 |
| 132 | regulation of acute inflammatory response (GO:0002673) | 3.32949433 |
| 133 | exogenous drug catabolic process (GO:0042738) | 10.4627054 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.25900118 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.07739304 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.71142772 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.45189207 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.28435435 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.02380445 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.95646607 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.93222394 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.81715204 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.58123189 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.02613432 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7759955 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98310893 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96849998 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.89367437 |
| 16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.65967932 |
| 17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58183869 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.55371114 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54683391 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.53714675 |
| 21 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.40548461 |
| 22 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.37956424 |
| 23 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34369678 |
| 24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.27622905 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.25109545 |
| 26 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22868300 |
| 27 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.22235888 |
| 28 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21473802 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.14123592 |
| 30 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.12713726 |
| 31 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.10516092 |
| 32 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.10109906 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04718783 |
| 34 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.02469873 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.00525186 |
| 36 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.99013852 |
| 37 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.97874005 |
| 38 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96526601 |
| 39 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.93479494 |
| 40 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90698107 |
| 41 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.90675609 |
| 42 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.89139489 |
| 43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88443572 |
| 44 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.87912072 |
| 45 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86372367 |
| 46 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.86134141 |
| 47 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.84714326 |
| 48 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.83510206 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82976903 |
| 50 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.82944495 |
| 51 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82323793 |
| 52 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.80818810 |
| 53 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79596908 |
| 54 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.78695688 |
| 55 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78108184 |
| 56 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.77888595 |
| 57 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.77159166 |
| 58 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.76960734 |
| 59 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.75315475 |
| 60 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.75297275 |
| 61 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.74594657 |
| 62 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73991216 |
| 63 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73872100 |
| 64 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.73634580 |
| 65 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.72806229 |
| 66 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.71416558 |
| 67 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.70168640 |
| 68 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.70073806 |
| 69 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.69719445 |
| 70 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.69435825 |
| 71 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.69316739 |
| 72 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.66609149 |
| 73 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.65288248 |
| 74 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.64740292 |
| 75 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.64460741 |
| 76 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.64197288 |
| 77 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.64095090 |
| 78 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.63834268 |
| 79 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.63834268 |
| 80 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.63728226 |
| 81 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.63196125 |
| 82 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.63196125 |
| 83 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.62620538 |
| 84 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.62341945 |
| 85 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.62099905 |
| 86 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.62099905 |
| 87 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.61381383 |
| 88 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.61094834 |
| 89 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.60992482 |
| 90 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60913333 |
| 91 | GATA2_19941826_ChIP-Seq_K562_Human | 0.60017575 |
| 92 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.59846334 |
| 93 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.59842061 |
| 94 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.59560391 |
| 95 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.59447452 |
| 96 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.58966588 |
| 97 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58782931 |
| 98 | NCOR_22424771_ChIP-Seq_293T_Human | 0.57912982 |
| 99 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.57695294 |
| 100 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.56866510 |
| 101 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.56782540 |
| 102 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.56547048 |
| 103 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.56456645 |
| 104 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56054305 |
| 105 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.55916683 |
| 106 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.55873671 |
| 107 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.55522082 |
| 108 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.54727791 |
| 109 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.54705471 |
| 110 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.54671847 |
| 111 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.54105668 |
| 112 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.53981215 |
| 113 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.53685980 |
| 114 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.53153597 |
| 115 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.53004661 |
| 116 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.52921288 |
| 117 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.52884297 |
| 118 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.52794964 |
| 119 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.52470674 |
| 120 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52308128 |
| 121 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.50666443 |
| 122 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50291548 |
| 123 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.50200916 |
| 124 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.48380227 |
| 125 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.47643670 |
| 126 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47601705 |
| 127 | AR_20517297_ChIP-Seq_VCAP_Human | 0.47188856 |
| 128 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.47013333 |
| 129 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.45710223 |
| 130 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.45600856 |
| 131 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.44830373 |
| 132 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.43341722 |
| 133 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.43214985 |
| 134 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43048141 |
| 135 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.42616514 |
| 136 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.42596337 |
| 137 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.42349200 |
| 138 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.41997228 |
| 139 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.41306571 |
| 140 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.40369917 |
| 141 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39559632 |
| 142 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.38872961 |
| 143 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.38828354 |
| 144 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.38763732 |
| 145 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.38353241 |
| 146 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38279669 |
| 147 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.37235632 |
| 148 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.36890896 |
| 149 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.36890746 |
| 150 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.36467603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.94887895 |
| 2 | MP0005360_urolithiasis | 7.30358033 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.15762639 |
| 4 | MP0005365_abnormal_bile_salt | 5.88836559 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.88143144 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.96232898 |
| 7 | MP0003252_abnormal_bile_duct | 3.72590187 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.58332700 |
| 9 | MP0009840_abnormal_foam_cell | 3.42253124 |
| 10 | MP0005083_abnormal_biliary_tract | 3.16411629 |
| 11 | MP0010368_abnormal_lymphatic_system | 2.83324036 |
| 12 | MP0003195_calcinosis | 2.66307501 |
| 13 | MP0005332_abnormal_amino_acid | 2.58042585 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.44858132 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.42179695 |
| 16 | MP0000609_abnormal_liver_physiology | 2.16901931 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.07588677 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.02745188 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.01354272 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82808823 |
| 21 | MP0003868_abnormal_feces_composition | 1.82254484 |
| 22 | MP0009697_abnormal_copulation | 1.78266680 |
| 23 | MP0001764_abnormal_homeostasis | 1.51346118 |
| 24 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.48219206 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 1.47063411 |
| 26 | MP0003656_abnormal_erythrocyte_physiolo | 1.46028390 |
| 27 | MP0005451_abnormal_body_composition | 1.42791479 |
| 28 | MP0003011_delayed_dark_adaptation | 1.35655015 |
| 29 | MP0003186_abnormal_redox_activity | 1.30683004 |
| 30 | MP0002132_abnormal_respiratory_system | 1.27351541 |
| 31 | MP0000598_abnormal_liver_morphology | 1.24696696 |
| 32 | MP0009643_abnormal_urine_homeostasis | 1.20210897 |
| 33 | MP0000604_amyloidosis | 1.17956164 |
| 34 | MP0009764_decreased_sensitivity_to | 1.17822983 |
| 35 | MP0005647_abnormal_sex_gland | 1.13530396 |
| 36 | MP0009763_increased_sensitivity_to | 1.07169742 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 1.01820153 |
| 38 | MP0002282_abnormal_trachea_morphology | 1.01354063 |
| 39 | MP0001879_abnormal_lymphatic_vessel | 0.98938038 |
| 40 | MP0002254_reproductive_system_inflammat | 0.98664744 |
| 41 | MP0008469_abnormal_protein_level | 0.96590532 |
| 42 | MP0005636_abnormal_mineral_homeostasis | 0.86990545 |
| 43 | MP0008872_abnormal_physiological_respon | 0.86089987 |
| 44 | MP0009642_abnormal_blood_homeostasis | 0.85287110 |
| 45 | MP0005187_abnormal_penis_morphology | 0.84435506 |
| 46 | MP0005376_homeostasis/metabolism_phenot | 0.82465661 |
| 47 | MP0009765_abnormal_xenobiotic_induced | 0.78815345 |
| 48 | MP0005408_hypopigmentation | 0.78320744 |
| 49 | MP0005464_abnormal_platelet_physiology | 0.78250076 |
| 50 | MP0005084_abnormal_gallbladder_morpholo | 0.73799749 |
| 51 | MP0003690_abnormal_glial_cell | 0.73316276 |
| 52 | MP0003724_increased_susceptibility_to | 0.73253323 |
| 53 | MP0005670_abnormal_white_adipose | 0.71204688 |
| 54 | MP0004130_abnormal_muscle_cell | 0.70658050 |
| 55 | MP0002078_abnormal_glucose_homeostasis | 0.70314659 |
| 56 | MP0006036_abnormal_mitochondrial_physio | 0.67661401 |
| 57 | MP0003436_decreased_susceptibility_to | 0.64984026 |
| 58 | MP0002971_abnormal_brown_adipose | 0.64481896 |
| 59 | MP0009053_abnormal_anal_canal | 0.63654000 |
| 60 | MP0005220_abnormal_exocrine_pancreas | 0.62673502 |
| 61 | MP0000639_abnormal_adrenal_gland | 0.62458996 |
| 62 | MP0005334_abnormal_fat_pad | 0.62446092 |
| 63 | MP0005266_abnormal_metabolism | 0.60921911 |
| 64 | MP0003879_abnormal_hair_cell | 0.59807074 |
| 65 | MP0001756_abnormal_urination | 0.57474139 |
| 66 | MP0002249_abnormal_larynx_morphology | 0.56988398 |
| 67 | MP0000249_abnormal_blood_vessel | 0.56639000 |
| 68 | MP0001661_extended_life_span | 0.56275025 |
| 69 | MP0005535_abnormal_body_temperature | 0.55048373 |
| 70 | MP0004883_abnormal_blood_vessel | 0.54916530 |
| 71 | MP0003638_abnormal_response/metabolism_ | 0.54173756 |
| 72 | MP0004272_abnormal_basement_membrane | 0.53988435 |
| 73 | MP0000467_abnormal_esophagus_morphology | 0.53336179 |
| 74 | MP0006082_CNS_inflammation | 0.53045144 |
| 75 | MP0003329_amyloid_beta_deposits | 0.52880190 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 0.50610590 |
| 77 | MP0003075_altered_response_to | 0.50151679 |
| 78 | MP0003300_gastrointestinal_ulcer | 0.49881803 |
| 79 | MP0008873_increased_physiological_sensi | 0.48991924 |
| 80 | MP0002876_abnormal_thyroid_physiology | 0.48134008 |
| 81 | MP0002136_abnormal_kidney_physiology | 0.48086248 |
| 82 | MP0005058_abnormal_lysosome_morphology | 0.47893719 |
| 83 | MP0005448_abnormal_energy_balance | 0.46563011 |
| 84 | MP0005395_other_phenotype | 0.46497355 |
| 85 | MP0005164_abnormal_response_to | 0.45769813 |
| 86 | MP0008874_decreased_physiological_sensi | 0.45754303 |
| 87 | MP0005166_decreased_susceptibility_to | 0.44990915 |
| 88 | MP0001915_intracranial_hemorrhage | 0.43499856 |
| 89 | MP0009785_altered_susceptibility_to | 0.43158500 |
| 90 | MP0001243_abnormal_dermal_layer | 0.42056309 |
| 91 | MP0003718_maternal_effect | 0.39954042 |
| 92 | MP0003303_peritoneal_inflammation | 0.39774813 |
| 93 | MP0005595_abnormal_vascular_smooth | 0.39356031 |
| 94 | MP0002928_abnormal_bile_duct | 0.39295627 |
| 95 | MP0002128_abnormal_blood_circulation | 0.39123327 |
| 96 | MP0004264_abnormal_extraembryonic_tissu | 0.39112097 |
| 97 | MP0000230_abnormal_systemic_arterial | 0.38757122 |
| 98 | MP0001845_abnormal_inflammatory_respons | 0.38644840 |
| 99 | MP0006035_abnormal_mitochondrial_morpho | 0.38319805 |
| 100 | MP0000013_abnormal_adipose_tissue | 0.35691504 |
| 101 | MP0002295_abnormal_pulmonary_circulatio | 0.34931683 |
| 102 | MP0005023_abnormal_wound_healing | 0.34333337 |
| 103 | MP0002332_abnormal_exercise_endurance | 0.32490841 |
| 104 | MP0003953_abnormal_hormone_level | 0.32272933 |
| 105 | MP0005248_abnormal_Harderian_gland | 0.32078384 |
| 106 | MP0009672_abnormal_birth_weight | 0.31817204 |
| 107 | MP0005666_abnormal_adipose_tissue | 0.31545191 |
| 108 | MP0009115_abnormal_fat_cell | 0.30777174 |
| 109 | MP0002168_other_aberrant_phenotype | 0.30556806 |
| 110 | MP0002419_abnormal_innate_immunity | 0.30124225 |
| 111 | MP0005409_darkened_coat_color | 0.25878180 |
| 112 | MP0003183_abnormal_peptide_metabolism | 0.23804373 |
| 113 | MP0005165_increased_susceptibility_to | 0.22121997 |
| 114 | MP0003633_abnormal_nervous_system | 0.20713926 |
| 115 | MP0010155_abnormal_intestine_physiology | 0.20435123 |
| 116 | MP0001986_abnormal_taste_sensitivity | 0.20018698 |
| 117 | MP0001851_eye_inflammation | 0.19214726 |
| 118 | MP0006054_spinal_hemorrhage | 0.19212889 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.61076393 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.10974963 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.06845459 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.56919213 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.40627800 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.26349603 |
| 7 | Xanthomatosis (HP:0000991) | 6.24432039 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.51309384 |
| 9 | Complement deficiency (HP:0004431) | 5.15565688 |
| 10 | Joint hemorrhage (HP:0005261) | 5.11129485 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.81024783 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.50645461 |
| 13 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.41579680 |
| 14 | Hyperammonemia (HP:0001987) | 4.39629719 |
| 15 | Epidermoid cyst (HP:0200040) | 4.34864190 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.32243036 |
| 17 | Hyperglycinemia (HP:0002154) | 4.11298449 |
| 18 | Abnormality of methionine metabolism (HP:0010901) | 4.08870601 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.05878538 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.01069262 |
| 21 | Fat malabsorption (HP:0002630) | 4.00116199 |
| 22 | Ketosis (HP:0001946) | 3.99725191 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.90316919 |
| 24 | Abnormality of the intrinsic pathway (HP:0010989) | 3.86258883 |
| 25 | Abnormality of complement system (HP:0005339) | 3.83710262 |
| 26 | Hypercholesterolemia (HP:0003124) | 3.70951326 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.69099657 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.68453655 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.64419491 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.64419491 |
| 31 | Hyperglycinuria (HP:0003108) | 3.63619934 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.47907654 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.32346368 |
| 34 | Myocardial infarction (HP:0001658) | 3.17684456 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.17426423 |
| 36 | Hepatocellular carcinoma (HP:0001402) | 3.15735191 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.13574477 |
| 38 | Spontaneous abortion (HP:0005268) | 3.02969644 |
| 39 | Steatorrhea (HP:0002570) | 3.01409067 |
| 40 | Hypochromic microcytic anemia (HP:0004840) | 3.01066223 |
| 41 | Delayed CNS myelination (HP:0002188) | 2.93390533 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 2.92253376 |
| 43 | Systemic lupus erythematosus (HP:0002725) | 2.81737957 |
| 44 | Abnormality of serum amino acid levels (HP:0003112) | 2.79678566 |
| 45 | Osteomalacia (HP:0002749) | 2.78015158 |
| 46 | Skin nodule (HP:0200036) | 2.77267239 |
| 47 | Ketoacidosis (HP:0001993) | 2.74161129 |
| 48 | Esophageal varix (HP:0002040) | 2.71515511 |
| 49 | Acanthocytosis (HP:0001927) | 2.71474638 |
| 50 | Vascular calcification (HP:0004934) | 2.68273267 |
| 51 | Neonatal hypoglycemia (HP:0001998) | 2.64923329 |
| 52 | Metabolic acidosis (HP:0001942) | 2.60057784 |
| 53 | Glomerulonephritis (HP:0000099) | 2.57677713 |
| 54 | Abnormality of purine metabolism (HP:0004352) | 2.54153237 |
| 55 | Abnormal gallbladder morphology (HP:0012437) | 2.53668937 |
| 56 | Cholelithiasis (HP:0001081) | 2.50134258 |
| 57 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.49079857 |
| 58 | Amyloidosis (HP:0011034) | 2.46781469 |
| 59 | Mitral stenosis (HP:0001718) | 2.45085038 |
| 60 | Spastic diplegia (HP:0001264) | 2.44742804 |
| 61 | Menorrhagia (HP:0000132) | 2.43719084 |
| 62 | Gingival bleeding (HP:0000225) | 2.43459721 |
| 63 | Cholecystitis (HP:0001082) | 2.42881447 |
| 64 | Abnormal gallbladder physiology (HP:0012438) | 2.42881447 |
| 65 | Hemorrhage of the eye (HP:0011885) | 2.42186930 |
| 66 | Dicarboxylic aciduria (HP:0003215) | 2.41468334 |
| 67 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.41468334 |
| 68 | Cardiovascular calcification (HP:0011915) | 2.41123282 |
| 69 | Fair hair (HP:0002286) | 2.37262075 |
| 70 | Lethargy (HP:0001254) | 2.34538610 |
| 71 | Thrombophlebitis (HP:0004418) | 2.33521559 |
| 72 | Hypoglycemic seizures (HP:0002173) | 2.29865236 |
| 73 | Poikilocytosis (HP:0004447) | 2.25453393 |
| 74 | Purpura (HP:0000979) | 2.24120183 |
| 75 | Irritability (HP:0000737) | 2.21336438 |
| 76 | Neonatal onset (HP:0003623) | 2.21222852 |
| 77 | Malnutrition (HP:0004395) | 2.17932227 |
| 78 | Joint swelling (HP:0001386) | 2.14823310 |
| 79 | Gout (HP:0001997) | 2.14041450 |
| 80 | Abnormality of vitamin metabolism (HP:0100508) | 2.13448269 |
| 81 | Cerebral edema (HP:0002181) | 2.12027643 |
| 82 | Sensorimotor neuropathy (HP:0007141) | 2.11841305 |
| 83 | Pancreatitis (HP:0001733) | 2.07540877 |
| 84 | Abnormality of iron homeostasis (HP:0011031) | 2.07449794 |
| 85 | Glycosuria (HP:0003076) | 2.06552500 |
| 86 | Abnormality of urine glucose concentration (HP:0011016) | 2.06552500 |
| 87 | Abnormality of the gallbladder (HP:0005264) | 2.05441056 |
| 88 | Polycythemia (HP:0001901) | 2.05382279 |
| 89 | Hyperphosphaturia (HP:0003109) | 2.02679987 |
| 90 | Enlarged kidneys (HP:0000105) | 2.02196699 |
| 91 | Elevated alkaline phosphatase (HP:0003155) | 2.01926246 |
| 92 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.99183953 |
| 93 | Brushfield spots (HP:0001088) | 1.98922095 |
| 94 | Reticulocytosis (HP:0001923) | 1.98883266 |
| 95 | Pulmonary embolism (HP:0002204) | 1.95576854 |
| 96 | Opisthotonus (HP:0002179) | 1.94525142 |
| 97 | Vomiting (HP:0002013) | 1.94472062 |
| 98 | Late onset (HP:0003584) | 1.93280332 |
| 99 | Abnormality of proline metabolism (HP:0010907) | 1.91901223 |
| 100 | Hydroxyprolinuria (HP:0003080) | 1.91901223 |
| 101 | Nonimmune hydrops fetalis (HP:0001790) | 1.90399078 |
| 102 | Rickets (HP:0002748) | 1.87976048 |
| 103 | Conjunctival telangiectasia (HP:0000524) | 1.87312331 |
| 104 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.85640560 |
| 105 | Nephritis (HP:0000123) | 1.85145558 |
| 106 | Abnormal cartilage morphology (HP:0002763) | 1.84363331 |
| 107 | Generalized aminoaciduria (HP:0002909) | 1.83048787 |
| 108 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.81869475 |
| 109 | Hypophosphatemic rickets (HP:0004912) | 1.80809920 |
| 110 | Stroke (HP:0001297) | 1.80445304 |
| 111 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.80262869 |
| 112 | Increased mean platelet volume (HP:0011877) | 1.80219407 |
| 113 | Epistaxis (HP:0000421) | 1.80191849 |
| 114 | Cerebral palsy (HP:0100021) | 1.78843937 |
| 115 | Abnormal delivery (HP:0001787) | 1.77918719 |
| 116 | Reduced antithrombin III activity (HP:0001976) | 1.69784892 |
| 117 | Abnormal urine phosphate concentration (HP:0012599) | 1.68136800 |
| 118 | Atrioventricular block (HP:0001678) | 1.66734765 |
| 119 | Facial shape deformation (HP:0011334) | 1.61980901 |
| 120 | Potter facies (HP:0002009) | 1.61980901 |
| 121 | Arthropathy (HP:0003040) | 1.59151842 |
| 122 | Generalized hypopigmentation of hair (HP:0011358) | 1.57430229 |
| 123 | Nephrolithiasis (HP:0000787) | 1.51078348 |
| 124 | Increased serum ferritin (HP:0003281) | 1.50473846 |
| 125 | Alkalosis (HP:0001948) | 1.47107082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.66445923 |
| 2 | MAP3K12 | 4.82365681 |
| 3 | KDR | 4.80639009 |
| 4 | TIE1 | 4.64824596 |
| 5 | ERN1 | 4.52935540 |
| 6 | FGFR4 | 3.95110508 |
| 7 | SIK1 | 3.83730461 |
| 8 | PDK2 | 2.83331129 |
| 9 | PKN2 | 2.82934457 |
| 10 | MYLK | 2.64322588 |
| 11 | TAOK3 | 2.57809715 |
| 12 | ERBB4 | 2.30504488 |
| 13 | FER | 2.18395299 |
| 14 | ARAF | 2.14392649 |
| 15 | MST1R | 2.13721035 |
| 16 | INSRR | 2.06906265 |
| 17 | TRIB3 | 2.04517899 |
| 18 | AKT3 | 1.92122778 |
| 19 | FLT3 | 1.84312181 |
| 20 | TGFBR2 | 1.83387506 |
| 21 | MAP4K2 | 1.82304946 |
| 22 | ACVR1B | 1.80641606 |
| 23 | PTK6 | 1.78423082 |
| 24 | MAP2K4 | 1.78120900 |
| 25 | TYK2 | 1.72745034 |
| 26 | EPHA4 | 1.70857265 |
| 27 | WNK3 | 1.65158841 |
| 28 | MAPK11 | 1.61381662 |
| 29 | MAP2K3 | 1.51050018 |
| 30 | NEK9 | 1.35586513 |
| 31 | TBK1 | 1.34878279 |
| 32 | PIK3CA | 1.34552852 |
| 33 | PIK3CG | 1.33896136 |
| 34 | LATS1 | 1.32888337 |
| 35 | DAPK2 | 1.28534590 |
| 36 | ABL2 | 1.25269858 |
| 37 | JAK2 | 1.22721961 |
| 38 | MAP3K11 | 1.17896894 |
| 39 | MAP3K9 | 1.11687473 |
| 40 | ILK | 1.09133116 |
| 41 | MAP3K3 | 1.08308293 |
| 42 | JAK1 | 1.07438690 |
| 43 | MAP3K13 | 1.05483721 |
| 44 | EPHB1 | 1.05457500 |
| 45 | MET | 1.03526420 |
| 46 | NLK | 1.02325975 |
| 47 | RIPK1 | 0.98771060 |
| 48 | MAP3K10 | 0.98734875 |
| 49 | PRKAA2 | 0.96425274 |
| 50 | FGFR2 | 0.95646860 |
| 51 | MAP3K14 | 0.95584883 |
| 52 | MAP3K2 | 0.94645531 |
| 53 | GRK1 | 0.92702533 |
| 54 | GRK6 | 0.91208174 |
| 55 | MAPK12 | 0.88061447 |
| 56 | MAP3K7 | 0.85473237 |
| 57 | CSK | 0.85342202 |
| 58 | MAPK4 | 0.84177882 |
| 59 | ERBB2 | 0.83224017 |
| 60 | CDK6 | 0.82357519 |
| 61 | PRKCG | 0.76945722 |
| 62 | PTK2 | 0.76417141 |
| 63 | MAP4K1 | 0.75903255 |
| 64 | PTK2B | 0.75736814 |
| 65 | TGFBR1 | 0.75160891 |
| 66 | PRKG1 | 0.74574162 |
| 67 | PRKCZ | 0.68248105 |
| 68 | STK16 | 0.68166643 |
| 69 | NTRK3 | 0.67580651 |
| 70 | FRK | 0.66878659 |
| 71 | PRKACG | 0.65719611 |
| 72 | BMPR1B | 0.63505656 |
| 73 | GSK3A | 0.61710970 |
| 74 | PRKACA | 0.59184102 |
| 75 | BMX | 0.58963012 |
| 76 | KSR1 | 0.57329729 |
| 77 | IKBKE | 0.57081396 |
| 78 | KSR2 | 0.56454702 |
| 79 | DYRK1B | 0.55755847 |
| 80 | CSF1R | 0.55193523 |
| 81 | EPHA2 | 0.54887877 |
| 82 | PINK1 | 0.53384586 |
| 83 | RET | 0.53085820 |
| 84 | IRAK3 | 0.52459250 |
| 85 | MAPK7 | 0.52126737 |
| 86 | CAMK1D | 0.52012536 |
| 87 | EPHB2 | 0.51747039 |
| 88 | IGF1R | 0.50636858 |
| 89 | PRKCE | 0.50178946 |
| 90 | KIT | 0.50077850 |
| 91 | EPHA3 | 0.49355613 |
| 92 | SRC | 0.49103238 |
| 93 | FGFR3 | 0.49044080 |
| 94 | EGFR | 0.48833120 |
| 95 | FES | 0.48118458 |
| 96 | PAK4 | 0.47548136 |
| 97 | PRKG2 | 0.47501373 |
| 98 | PRKCA | 0.47435393 |
| 99 | MAP2K1 | 0.46986831 |
| 100 | PRKAA1 | 0.46725804 |
| 101 | BRAF | 0.45866301 |
| 102 | PDPK1 | 0.44005247 |
| 103 | SGK3 | 0.42533460 |
| 104 | MAP3K1 | 0.41844278 |
| 105 | MAP2K6 | 0.41807006 |
| 106 | TNK2 | 0.41243179 |
| 107 | PRKCQ | 0.40462587 |
| 108 | PBK | 0.39972617 |
| 109 | MOS | 0.38889596 |
| 110 | ZAP70 | 0.37878080 |
| 111 | MAPK15 | 0.37218573 |
| 112 | TAOK2 | 0.37201097 |
| 113 | PRKACB | 0.36978836 |
| 114 | CSNK1D | 0.36127531 |
| 115 | STK38L | 0.34864185 |
| 116 | YES1 | 0.34578795 |
| 117 | CAMK2G | 0.34571296 |
| 118 | SGK494 | 0.34254455 |
| 119 | SGK223 | 0.34254455 |
| 120 | SGK2 | 0.33782576 |
| 121 | CDK4 | 0.33144539 |
| 122 | DAPK1 | 0.33114515 |
| 123 | JAK3 | 0.31567558 |
| 124 | MTOR | 0.31315132 |
| 125 | MAP2K2 | 0.30927128 |
| 126 | BLK | 0.30635172 |
| 127 | MAP3K5 | 0.30512845 |
| 128 | PRKCB | 0.29436641 |
| 129 | ICK | 0.28986518 |
| 130 | CAMK4 | 0.28681217 |
| 131 | CDK9 | 0.28390741 |
| 132 | ITK | 0.28336953 |
| 133 | PDK1 | 0.26581008 |
| 134 | CSNK1G1 | 0.26403272 |
| 135 | OBSCN | 0.25590755 |
| 136 | LYN | 0.24660421 |
| 137 | RPS6KA3 | 0.24513414 |
| 138 | ABL1 | 0.24221247 |
| 139 | ROCK1 | 0.23714970 |
| 140 | PAK3 | 0.22460436 |
| 141 | STK3 | 0.22437676 |
| 142 | LRRK2 | 0.22108198 |
| 143 | BCR | 0.21490027 |
| 144 | STK10 | 0.17587562 |
| 145 | MAP3K6 | 0.17274538 |
| 146 | PDGFRA | 0.17217869 |
| 147 | CHUK | 0.16653625 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.56635886 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.70645887 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.40424155 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.31986380 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.16475144 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.00359741 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.75342738 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65481206 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.61841010 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.49922143 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48388523 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.31361384 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.29420552 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.10032380 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09595112 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.05700133 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.95315993 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93022267 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91954414 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88765407 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.88658420 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.88410447 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84703842 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80076504 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79695881 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.72799557 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.67717289 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.66547379 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.66384473 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60195759 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.57237159 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.56935391 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.54410950 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49278614 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.42208109 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.40585128 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.36084949 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30341156 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29196233 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.29169972 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28718239 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.24446881 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23347470 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22912688 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18068571 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16574593 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13816251 |
| 48 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.11558976 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.09078830 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95293380 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92283867 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.91423208 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.91259592 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89554209 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.85890340 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.85601366 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84057003 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80621718 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.79811682 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75759483 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68599660 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65609145 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.60677467 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57397136 |
| 65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51834310 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47682246 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41912846 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.35723034 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.33594903 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31711378 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.27079928 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23602618 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.19717695 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19516499 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.17339933 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.13384057 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.11504299 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09783588 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.08530908 |
| 80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.07612491 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04120307 |
| 82 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.03958592 |
| 83 | Other glycan degradation_Homo sapiens_hsa00511 | 0.01032668 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00024607 |
| 85 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2597612 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.2195094 |
| 87 | Platelet activation_Homo sapiens_hsa04611 | -0.2115124 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2100499 |
| 89 | Bladder cancer_Homo sapiens_hsa05219 | -0.2014275 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1993165 |
| 91 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1926420 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1825116 |
| 93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1741205 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1508555 |
| 95 | Pertussis_Homo sapiens_hsa05133 | -0.1478251 |
| 96 | Lysosome_Homo sapiens_hsa04142 | -0.1448102 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1377893 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | -0.1296219 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1249460 |
| 100 | Malaria_Homo sapiens_hsa05144 | -0.1219258 |
| 101 | Hepatitis C_Homo sapiens_hsa05160 | -0.1149913 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1133122 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1118657 |
| 104 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1032900 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0860614 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0848599 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0669532 |
| 108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0623080 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0480813 |
| 110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0312072 |
| 111 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0124561 |

